“…In light of this, it is interesting to note that stimulation of neurotransmitter receptors such as muscarinic acetylcholine receptors results in prolonged activation of ERK1/2 both in vitro and in vivo (Rosenblum et al, 2000). A variety of agents such as ligands for specific neurotransmitter receptors (Ferraguti et al, 1999;Hayashi et al, 1999;Mukherjee et al, 1999;Yan et al, 1999), nitric oxide (Yun et al, 1998), and estrogen (Singh et al, 1999) can activate the neuronal ERK pathway in vitro. A search for agents that can activate the ERK pathway or its downstream mediators in neurons in vivo seems warranted to attempt to develop better therapies against neonatal H-I brain injury.…”